Patents
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
02/2013
02/20/2013CN102939107A Antibody preparations
02/20/2013CN102939106A Protein formulations
02/20/2013CN102939105A Immunogenic compositions and related methods
02/20/2013CN102939104A Concentration of vaccine antigens with lyophilization
02/20/2013CN102939103A Influenza virus vaccines and uses thereof
02/20/2013CN102939102A Recombinant multimeric influenza proteins
02/20/2013CN102939101A Influenza virus compositions and methods for universal vaccines
02/20/2013CN102939100A Enzymatic composition for the digestion of chicken embryos
02/20/2013CN102939099A Treating allergy with detoxified e. coli heat-labile enterotoxin
02/20/2013CN102939098A Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
02/20/2013CN102936287A Antibody capable of binding specifically to A beta-oligomer, and use thereof
02/20/2013CN102936286A Anti-anthrax PA antigen monoclonal antibody and applications thereof
02/20/2013CN102936285A Antibody for preventing and treating fish Edwardsiellaictaluri disease, preparation method and applications thereof
02/20/2013CN102936284A 人抗狂犬病抗体及其用途 Human anti-rabies antibodies and their use
02/20/2013CN102936283A Anti-human CD146 monoclonal antibodies, compositions containing anti-human CD146 monoclonal antibodies, and soluble CD146 detection method
02/20/2013CN102936278A Epitope polypeptide of dengue virus type 2 NS3 protein and application thereof
02/20/2013CN102936277A Human blood vessel endothelial growth factor antigen epitope and epitope vaccine thereof
02/20/2013CN102935240A Rabbit hemorrhagic disease virus (RHDV) 'suicide' deoxyribonucleic acid (DNA) vaccine and construction method thereof
02/20/2013CN102935228A Reagent for tumor treatment, its use and method
02/20/2013CN102935227A Newcastle disease virus hemagglutinin-neuraminidase (HN) gene subunit vaccine and preparation method thereof
02/20/2013CN102935226A Typhoid fever and paratyphoid fever combined vaccine and preparation method thereof
02/20/2013CN102344892B Chinese isolate of Leachiii mycoplasma, isolation culture medium and purpose thereof
02/20/2013CN102309759B Poultry freeze-drying live vaccine heat-resisting protective agent and preparation method thereof
02/20/2013CN102233137B Recombinant plasmid DNA vaccine composition for treating Hepatitis B
02/20/2013CN101573384B Antibodies and immunoconjugates and uses therefor
02/20/2013CN101478984B Compositions and methods for treating parasitic infections
02/19/2013USRE44024 Isolation and characterization of ECA1, a gene overexpressed in endometroid carcinomas of ovary and endometrium
02/19/2013US8378087 Recombinant Plasmodium falciparum merozoite surface proteins 4 and 5 and their use
02/19/2013US8378081 Antibodies that specifically bind to Aβ oligomers and uses thereof
02/19/2013US8377959 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
02/19/2013US8377945 Small molecule inhibitors of spleen tyrosine kinase (SYK)
02/19/2013US8377690 Cells and methods for producing blocking antibodies to human RANKL
02/19/2013US8377645 Unc-33 like phosphoprotein (ULIP) polypeptide for generating antibodies for use in diagnosis, preventnion and treatment of neurodegenerative and neoplastic disorders
02/19/2013US8377477 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof
02/19/2013US8377452 Use of a botulinum neurotoxin to alleviate various disorders
02/19/2013US8377451 Polysaccharide-staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
02/19/2013US8377450 Clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer
02/19/2013US8377448 CD47 related compositions and methods for treating immunological diseases and disorders
02/19/2013US8377447 Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells
02/19/2013US8377446 Serum resistance factors of gram positive bacteria
02/19/2013US8377445 Compositions of human lipids and methods of making and using same
02/19/2013US8377444 Therapeutic agent or preventive agent for osteoarthritis
02/19/2013US8377443 Antibodies to matrix metalloproteinase 9
02/19/2013US8377442 Method of treating inflammatory eye disease with IL-1β binding antibodies
02/19/2013US8377441 Treating breast cancer with anti-IL-19 antibody
02/19/2013US8377440 Anti-P-selectin antibodies and methods of using the same to treat inflammatory diseases
02/19/2013US8377439 Antagonist antibodies against EPHB3
02/19/2013US8377438 Methods of antagonizing signal transduction in spinal cord cells
02/19/2013US8377437 C3b antibodies and methods for the prevention and treatment of complement-associated disorders
02/19/2013US8377436 Granulysin and uses thereof
02/19/2013US8377435 Antibody induced cell membrane wounding
02/19/2013US8377429 Methods for improvement of beta cell function with anti-IL-1β antibodies or fragments thereof
02/19/2013US8377420 Injectable void filler for soft tissue augmentation
02/19/2013CA2497279C Mutant forms of meningococcal adp-ribosylating toxin
02/19/2013CA2487137C Tumour-associated peptides that bind to mhc molecules
02/19/2013CA2485120C Identification of novel broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies
02/19/2013CA2469092C Copolymer 1 vaccine and methods for treatment of amyotrophic lateral sclerosis (als)
02/19/2013CA2467930C Treatment of pml targeting jc virus agno
02/19/2013CA2443088C Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
02/19/2013CA2442964C Improved anti-inflammatory herbal composition and method of use
02/19/2013CA2375320C Dna vaccines for pets or for animals used in sports
02/19/2013CA2276450C A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent
02/19/2013CA2233570C Detection, prevention and treatment of papillomatous digital dermatitis
02/14/2013WO2013023162A2 Anti-muc1 antibodies for cancer diagnostics
02/14/2013WO2013023059A2 Methods and compositions for the treatment of autoimmune and inflammatory diseases
02/14/2013WO2013023043A2 Treatment of advanced solid tumors using combination of anti-erbb3 immunotherapy and selected chemotherapy
02/14/2013WO2013022991A2 Methods and compositions relating to p62 for the treatment and prophylaxis of cancer
02/14/2013WO2013022972A1 Methods of treating progressive forms of multiple sclerosis
02/14/2013WO2013022968A1 Antibodies binding to phosphorylcholine (pc) and/or pc conjugates
02/14/2013WO2013022848A1 Anti-polyubiquitin antibodies and methods of use
02/14/2013WO2013022808A2 Immunogenic protein conjugates and methods for making and using the same
02/14/2013WO2013022599A1 Improved methods and compositions for modulation of olfml3 mediated angiogenesis
02/14/2013WO2013022406A1 Angiopoietin-like 4 and its use in modulating cell leakiness
02/14/2013WO2013022091A1 Therapeutic agent for autoimmune diseases comprising pd-1 agonist
02/14/2013WO2013021279A2 Highly galactosylated antibodies
02/14/2013WO2013020995A1 New antibodies against phosphorylcholine
02/14/2013WO2013020988A1 Pasteurellaceae vaccines
02/14/2013WO2013020724A1 Composition comprising a tlr agonist and an antibody specific for an antigen and uses thereof as vaccine
02/14/2013WO2013020723A1 Compositions and uses thereof for the treatment or prevention of alzheimer's disease
02/14/2013WO2013020722A2 Compositions and uses
02/14/2013WO2013020372A1 Methods and reagents for preventing and curing insulin resistance and diabetes mellitus
02/14/2013WO2013020235A1 Methods and compositions for modulating voltage-gated calcium channel function
02/14/2013WO2013020183A1 Immunogenic compositions and methods therefor
02/14/2013WO2012143382A9 Gpr177 as target and marker in tumors
02/14/2013US20130041307 Application of beta-functionalized dihydroxy-chlorins for pdt
02/14/2013US20130041137 von Willebrand Factor (vWF) - Cleaving Protease
02/14/2013US20130040879 Methods For Treating Congestive Heart Failure
02/14/2013US20130039986 Silk-Based Ionomeric Compositions
02/14/2013US20130039974 Anti-muc1 antibodies for cancer diagnostics
02/14/2013US20130039973 Viral Immunogenic Compositions
02/14/2013US20130039971 Compositions and methods for inhibition of vegf
02/14/2013US20130039958 Method of vaccination
02/14/2013US20130039954 Control of antibody responses to synthetic nanocarriers
02/14/2013US20130039947 Novel immunogens and methods for discovery and screening thereof
02/14/2013US20130039946 Vaccine comprising an attenuated pestivirus
02/14/2013US20130039945 Anti-Viral Compounds
02/14/2013US20130039944 Anti-Viral Compounds
02/14/2013US20130039943 Novel method
02/14/2013US20130039942 Compositions and Methods for Self-Adjuvanting Vaccines against Microbes and Tumors
02/14/2013US20130039941 Vaccine comprising inactivated cells of haemophilus parasuis bacteria of serotype 5